Synthetic biology market size has grown from $4.2B in 2014 to $9.5B in 2021; it is estimated to reach $30.7B by 2026.
❤33👍25👀12
In past biotech companies tended to be founded with a focus on a single technology or biological pathway.
Over the past five years an innovative business model has emerged for biotech. In it, a portfolio manager controls a set of companies spanning multiple technologies and disease areas.
Instead of focusing on a single technology or in the traditional way, the portfolio manager uses a distinctive form of expertise — such as in fundraising, investment, venture creation, R&D, manufacturing, commercial management, leadership, and broad credibility — to start a suite of subsidiaries, each dedicated to an individual drug program.
Over the past five years an innovative business model has emerged for biotech. In it, a portfolio manager controls a set of companies spanning multiple technologies and disease areas.
Instead of focusing on a single technology or in the traditional way, the portfolio manager uses a distinctive form of expertise — such as in fundraising, investment, venture creation, R&D, manufacturing, commercial management, leadership, and broad credibility — to start a suite of subsidiaries, each dedicated to an individual drug program.
❤14👍7
Global market for gene editing will grow at a compound annual growth rate of 33.26% from $551.2 million in 2017 to $3.087 billion in 2023.
The North American market will account for the largest share of the gene editing market due to “increasing awareness of technology, proximity of companies, and early adoption of latest treatments.”
Asia was expected to be the second-largest market, due to “increasing government funding of research, economic prosperity, early adoption of latest technology and the relaxed”.
The North American market will account for the largest share of the gene editing market due to “increasing awareness of technology, proximity of companies, and early adoption of latest treatments.”
Asia was expected to be the second-largest market, due to “increasing government funding of research, economic prosperity, early adoption of latest technology and the relaxed”.
❤14👍6
The total amount of VC funding in AI-biotech startups increased in 2020 (as of November) by around 23%, compared to 2019, approaching a total of $1.9B, which is also more than in 2015, 2016 and 2017 combined.
An important driver of growth for the sector is a substantial shift in Big Pharma’s interest in AI technology from “nice to try” to “strategically important”.
An important driver of growth for the sector is a substantial shift in Big Pharma’s interest in AI technology from “nice to try” to “strategically important”.
👍9
Demand for blood is steadily growing:
— 81 million blood donations were collected in 2004;
— 108 million were collected in 2015;
— 118.5 million blood donations are collected globally nowadays.
Great opportunity for artificial blood companies?
— 81 million blood donations were collected in 2004;
— 108 million were collected in 2015;
— 118.5 million blood donations are collected globally nowadays.
Great opportunity for artificial blood companies?
👍18❤10
Nanotechonology market size is estimated at $42.2B in 2020 and is expected to reach $70.7B by 2026
👍17
Artificial blood market size — $2.1B in 2019 with a potential to reach $15.4B by 2027.
95% of the market size shares two blood substitutes that carry out functions of transporting oxygen and carbon dioxide:
— The first one is called hemoglobin-based oxygen carrier and has over 53%;
— the second one is perfluorocarbon emulsion and has approximately 42%.
95% of the market size shares two blood substitutes that carry out functions of transporting oxygen and carbon dioxide:
— The first one is called hemoglobin-based oxygen carrier and has over 53%;
— the second one is perfluorocarbon emulsion and has approximately 42%.
👍17
Nanorobotics market size is estimated to grow from $4.9B in 2018 to $8.3B by 2023.
Source: Markets and Markets
Source: Markets and Markets
👍5
3D bioprinting market size was estimated at $724.17M in 2020, and is projected to reach $2.39B by 2026
❤3👍3
#subscriberquestion
How to convince investors?
1. Be formidable
Investors decide in the first few minutes whether you seem like a winner or a loser.
2. Stick to the truth
Convince yourself that your startup is worth investing in, and then when you explain this to investors they'll believe you. I mean truly evaluate whether your startup is worth investing in. If it isn't, don't try to raise money.
3. Market
Founders think of startups as ideas, but investors think of them as markets. Your target market has to be big, and it also has to be capturable by you.
But the market doesn't have to be big yet, nor do you necessarily have to be in it yet. Indeed, it's often better to start in a small market that will either turn into a big one or from which you can move into a big one.
How to convince investors?
1. Be formidable
Investors decide in the first few minutes whether you seem like a winner or a loser.
2. Stick to the truth
Convince yourself that your startup is worth investing in, and then when you explain this to investors they'll believe you. I mean truly evaluate whether your startup is worth investing in. If it isn't, don't try to raise money.
3. Market
Founders think of startups as ideas, but investors think of them as markets. Your target market has to be big, and it also has to be capturable by you.
But the market doesn't have to be big yet, nor do you necessarily have to be in it yet. Indeed, it's often better to start in a small market that will either turn into a big one or from which you can move into a big one.
👍4
Are you going to invest in Chinese startups?
Anonymous Poll
12%
1. I used to but not now
31%
2. Yes, I will
31%
3. No I won't
25%
4. Not sure. 50/50